Delivery Order SPE2DB22D3301-SPE2DB25FY7EA
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,949.18 contract is for the supply of Adderall 5 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The award has a performance period extending through June 27, 2025 and is not designated as a set-aside contract, indicating open competition. Amerisourcebergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,141.71 delivery order contract is for the supply of Adderall 30 mg tablets, a prescription medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a firm fixed-price pricing type and a final completion date of December 14, 2023. Amerisourcebergen holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,744.65 firm fixed-price delivery order is for the supply of Adderall 10 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of December 9, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite...
- This federal contract award, valued at $9,846.66, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Adderall 10 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a firm fixed-price pricing type and an ultimate completion date of May 10, 2023. AmerisourceBergen holds a significant Indefinite...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,099.93 contract is for the supply of Adderall 10 mg tablets, a medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. The contract has an ultimate completion date of March 30, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 20mg Adderall tablets, a medication used to treat conditions such as Attention Deficit Hyperactivity Disorder (ADHD). The contract has a ceiling value of $1,613.99 and runs through January 30, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,183,344 tablets of Adderall 10mg, a prescription medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a ceiling value of $4,698.75 and a period of performance through May 9, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Adderall 15 mg tablets, a prescription medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a ceiling value of $3,660.01 and is a firm fixed-price, non-set-aside contract with a period of performance through May 8, 2025. Amerisourcebergen...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Adderall 10 mg tablets, a prescription medication, with a ceiling value of $1,266.02 and a period of performance through July 1, 2025. The contract is a Firm Fixed Price Delivery Order and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,676.86 delivery order is for the supply of Adderall 5 mg tablets, a controlled substance medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a firm fixed-price pricing type and an ultimate completion date of December 9, 2024. AmerisourceBergen holds a significant...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY7EADelivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Adderall 10 mg tablets, a prescription medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a ceiling value of $1,266.02 and is a firm fixed-price delivery order with a completion date of July 3, 2025. The contract is not set-aside and was awarded on July 2, 2025. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/2/25 |